Nymox Pharmaceutical Corp (NASDAQ:NYMX)
CAPS Rating:
A biopharmaceutical company with three proprietary products on the market and a R&D of drug & diagnostic products in development for the treatment of enlarged prostate, Alzheimer's disease contamination of food and drink products and bacterial infections.
RSS Headlines
Fool UK
Recs
what's to like going forward for several months anyway???